Health literacy and its association with human papilloma virus vaccination among adults: Findings from the behavioral risk factor surveillance system

References

• Diseases and related conditions: Sexually Transmitted Diseases (CDC). 2016. Centers for the disease control and prevention. accessed on May 28th 2022. https://www.cdc.gov/std/general/default.htm#:~:text=Human%20papillomavirus%20(HPV)%20is%20the,can%20be%20prevented%20with%20vaccines.
   Google Scholar
• Kreisel KM, Spicknall IH, Gargano JW, Lewis FMT, Lewis RM, Markowitz LE, Roberts H, Johnson AS, Song R, St Cyr SB, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021 Apr 1;48(4):1–8. doi:10.1097/OLQ.0000000000001355.
   PubMed Web of Science ®Google Scholar
• Dunne EF, Park IU. HPV and HPV-associated diseases. Infect Dis Clin North Am. 2013 Dec;27(4):765–78. doi:10.1016/j.idc.2013.09.001.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Laprise JF, Brisson M, Martin D, Ekwueme DU, Markowitz LE. The estimated lifetime medical cost of diseases attributable to human papillomavirus infections acquired in 2018. Sex Transm Dis. 2021 Apr 1;48(4):278–84. doi:10.1097/OLQ.0000000000001379.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Impact of vaccines universally recommended for children—the United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):243–48.
   PubMedGoogle Scholar
• Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008 Feb;86(2):140–46. doi:10.2471/blt.07.040089.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007 Mar 23;56(RR–2):1–24.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626–29. Erratum in: MMWR Morb Mortal Wkly Rep. 2010 Sep 17;59(36):1184.
   PubMedGoogle Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698–702. doi:10.15585/mmwr.mm6832a3.
   PubMed Web of Science ®Google Scholar
• Gardasil 9: Human Papillomavirus 9-valent Vaccine, Recombinant. The U.S. Food and Drug Administration. Accessed on June 02 2022. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9
   Google Scholar
• Chen MM, Mott N, Clark SJ, Harper DM, Shuman AG, Prince MEP, Dossett LA. HPV vaccination among young adults in the US. JAMA. 2021 Apr 27;325(16):1673–74. doi:10.1001/jama.2021.0725.
   PubMed Web of Science ®Google Scholar
• Boersma P, Black LI. Human papillomavirus vaccination among adults aged 18−26, 2013−2018. NCHS Data Brief, no 354. Hyattsville (MD): National Center for Health Statistics; 2020.
   Google Scholar
• Hirth J, McGrath CJ, Kuo YF, Rupp RE, Starkey JM, Berenson AB. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S. Vaccine. 2018 Nov 29;36(50):7682–88. doi:10.1016/j.vaccine.2018.10.075.
   PubMed Web of Science ®Google Scholar
• Williams CL, Walker TY, Elam-Evans LD, Yankey D, Fredua B, Saraiya M, Stokley S. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, national immunization survey-teen, 2016-2017. Hum Vaccin Immunother. 2020 Mar 3;16(3):562–72. doi:10.1080/21645515.2019.1670036.
   PubMed Web of Science ®Google Scholar
• Loretan C, Chamberlain AT, Sanchez T, Zlotorzynska M, Jones J. Trends and characteristics associated with human papillomavirus vaccination uptake among men who have sex with men in the United States, 2014-2017. Sex Transm Dis. 2019 Jul;46(7):465–73. doi:10.1097/OLQ.0000000000001008.
   PubMed Web of Science ®Google Scholar
• Fokom Domgue J, Cunningham SA, Yu RK, Shete S. Reasons for not receiving the HPV vaccine among eligible adults: lack of knowledge and of provider recommendations contribute more than safety and insurance concerns. Cancer Med. 2020 Jul;9(14):5281–90. doi:10.1002/cam4.3192.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Health literacy: a prescription to end confusion. Washington (DC): The National Academies Press; 2004.
   Google Scholar
• Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011 Jul 19;155(2):97–107. doi:10.7326/0003-4819-155-2-201107190-00005.
   PubMed Web of Science ®Google Scholar
• Gatwood J, Chiu CY, Shuvo S, Ramachandran S, Jadhav S, Hohmeier KC, Hagemann T. Role of social determinants of health in pneumococcal vaccination among high-risk adults. Vaccine. 2021 Apr 1;39(14):1951–62. doi:10.1016/j.vaccine.2021.02.061.
   PubMed Web of Science ®Google Scholar
• Shuvo S, Hagemann T, Hohmeier K, Chiu CY, Ramachandran S, Gatwood J. The role of social determinants in timely herpes zoster vaccination among older American adults. Hum Vaccin Immunother. 2021 Jan;30:1–7. doi:10.1080/21645515.2020.1856598.
   Google Scholar
• Lee HY, Lee J, Henning-Smith C, Choi J. HPV literacy and its link to initiation and completion of HPV vaccine among young adults in Minnesota. Public Health. 2017 Nov;152:172–78. doi:10.1016/j.puhe.2017.08.002.
   PubMed Web of Science ®Google Scholar
• Albright AE, Allen RS. HPV misconceptions among college students: the role of health literacy. J Community Health. 2018 Dec;43(6):1192–200. doi:10.1007/s10900-018-0539-4.
   PubMed Web of Science ®Google Scholar
• Kitur H, Horowitz AM, Beck K, Wang MQ. HPV knowledge, vaccine status, and health literacy among university students. J Cancer Educ. Mar 26 2021. doi:10.1007/s13187-021-01997-1.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2016 BRFSS overview. Accessed July 20 2021. https://www.cdc.gov/brfss/annual_data/2016/pdf/overview_2016.pdf
   Google Scholar
• Centers for Disease Control and Prevention. A health literacy report: analysis of 2016 BRFSS health literacy data. [accessed July 20 2021]. https://www.cdc.gov/healthliteracy/pdf/Report-on-2016-BRFSS-Health-Literacy-Data-For-Web.pdf
   Google Scholar
• Centers for Disease Control and Prevention.2016 Behavioral Risk Factor Surveillance System Questionnaire. [accessed July 21st 2021]. https://www.cdc.gov/brfss/questionnaires/pdf-ques/2016_BRFSS_Questionnaire_FINAL.pdf
   Google Scholar
• Luo H, Chen Z, Bell R, Rafferty AP, Gaskins Little NR, Winterbauer N. Health literacy and health behaviors among adults with prediabetes, 2016 behavioral risk factor surveillance system. Public Health Rep. 2020;135(4):492–500. doi:10.1177/0033354920927848.
   PubMed Web of Science ®Google Scholar
• Rafferty AP, Luo H, Winterbauer NL, Bell RA, Little NRG, Imai S. Health literacy among adults with multiple chronic health conditions. J Public Health Manag Pract. 2021 Apr 30;27(2):144–53. doi:10.1097/PHH.0000000000001050.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2010). National action plan to improve health literacy. Washington (DC). [accessed August 23rd 2021]. https://health.gov/sites/default/files/2019-09/Health_Literacy_Action_Plan.pdf
   Google Scholar
• McCormack L, Bann C, Squiers L, Berkman ND, Squire C, Schillinger D, Ohene-Frempong J, Hibbard J. Measuring health literacy: a pilot study of a new skills-based instrument. J Health Commun. 2010;15(Suppl 2):51–71. doi:10.1080/10810730.2010.499987.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718–23. doi:10.15585/mmwr.mm6833a2.
   PubMed Web of Science ®Google Scholar
• Lu PJ, O’Halloran A, Williams WW, Lindley MC, Farrall S, Bridges CB. Racial and ethnic disparities in vaccination coverage among adult populations in the U.S. Vaccine. 2015 Nov 27;33(Suppl 4):D83–91. doi:10.1016/j.vaccine.2015.09.031.
   PubMedGoogle Scholar
• Sriram S, Ranganathan R. Why human papillomavirus vaccination coverage is low among adolescents in the US? A study of barriers for vaccination uptake. J Family Med Prim Care. 2019;8(3):866–70. doi:10.4103/jfmpc.jfmpc_107_19.
   PubMedGoogle Scholar
• PB1 Boersma P, Black LI. Human papillomavirus vaccination among adults aged 18−26, 2013−2018. NCHS Data Brief, no 354. Hyattsville (MD): National Center for Health Statistics; 2020.
   Google Scholar
• PB 2 Sonawane K, Lin YY, Damgacioglu H, Zhu Y, Fernandez ME, Montealegre JR, Cazaban CG, Li R, Lairson DR, Lin Y, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Netw Open. 2021 Sep 1;4(9):e2124502. doi:10.1001/jamanetworkopen.2021.24502.
   PubMedGoogle Scholar
• Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, National SS, Regional. State, and selected local area vaccination coverage among adolescents aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109–16. doi:10.15585/mmwr.mm6933a1.
   PubMed Web of Science ®Google Scholar
• Rahman M, McGrath CJ, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States. Vaccine. 2014 May 1;32(21):2394–98. doi:10.1016/j.vaccine.2014.02.097.
   PubMed Web of Science ®Google Scholar
• Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11-17-year-old girls in the United States: national health interview survey, 2010. Vaccine. 2012;30(24):3534–40. doi:10.1016/j.vaccine.2012.03.067.
   PubMed Web of Science ®Google Scholar